FDA Drug · D-0108-2027

Vecuronium Bromide for Injection, 10mg, 10 Single-Dose Vials per carton, Sterile, Rx Only, Mfd. for Meitheal Pharmaceuticals, Chicago, IL. NDC: 71288-744-11

Class III · Ongoing

Labeling: Label Lacks Warning or Rx Legend

Affected lots / codes — check yours against thisLot# T1P0213A: Exp. 30-Apr-29 Lot# T1P0313A: Exp. 30-Apr-29 Lot# T1P0412A: Exp. 30-Sep-28 Lot# T1P0413A: Exp. 30-Apr-29 Lot# T1P0512A: Exp. 30-Sep-28 Lot# T1P0513A: Exp. 30-Apr-29

Recalling firm: Meitheal Pharmaceuticals, Inc, Chicago, IL
Classification: Class III (unlikely to cause harm)
Status: Ongoing
Quantity: 121,800 vials
Distribution: US. Nationwide
Recall initiated: October 8, 2026
Classified: October 29, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0108-2027%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →